RESTASIS
ABBVIE CORPORATION
Quick answers
Is there a shortage of RESTASIS in Canada?
No. There is no current shortage of RESTASIS 0.05% reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RESTASIS MULTIDOSE
ABBVIE CORPORATION
TEVA-CYCLOSPORINE
TEVA CANADA LIMITED
Other Products
CEQUA
SUN PHARMACEUTICAL INDUSTRIES LIMITED
VERKAZIA
APOTEX INC
SANDIMMUNE I.V.
NOVARTIS PHARMACEUTICALS CANADA INC
NEORAL
NOVARTIS PHARMACEUTICALS CANADA INC
DIN
02355655
Strength
0.05%
Dosage Form
Emulsion
Route
Ophthalmic
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from ABBVIE CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
150MG · DIN 02316838
35MG · DIN 02246896
35MG · DIN 02370417
0.5% · DIN 01968300
0.4% · DIN 02248722
0.45% · DIN 02369362
0.2% · DIN 02236876
0.15% · DIN 02248151
10MG · DIN 02443910
1400UNIT · DIN 02569086
100UNIT · DIN 01981501
50UNIT · DIN 02531577